The Ontario Institute for Cancer Research (OICR) is a collaborative research institute that conducts and enables high-impact translational cancer research. OIRC helps to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario.

The Drug Discovery team provides support and industry-caliber expertise for the province’s drug development community. It has established a strong pipeline of assets that are currently being translated to the clinic and are attracting global capital and other assets to Ontario.

свернуть